Product NDC: | 63323-412 |
Proprietary Name: | Midazolam |
Non Proprietary Name: | MIDAZOLAM HYDROCHLORIDE |
Active Ingredient(s): | 1 mg/mL & nbsp; MIDAZOLAM HYDROCHLORIDE |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-412 |
Labeler Name: | APP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA075154 |
Marketing Category: | ANDA |
Start Marketing Date: | 20000710 |
Package NDC: | 63323-412-05 |
Package Description: | 10 VIAL in 1 TRAY (63323-412-05) > 5 mL in 1 VIAL |
NDC Code | 63323-412-05 |
Proprietary Name | Midazolam |
Package Description | 10 VIAL in 1 TRAY (63323-412-05) > 5 mL in 1 VIAL |
Product NDC | 63323-412 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | MIDAZOLAM HYDROCHLORIDE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 20000710 |
Marketing Category Name | ANDA |
Labeler Name | APP Pharmaceuticals, LLC |
Substance Name | MIDAZOLAM HYDROCHLORIDE |
Strength Number | 1 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |